Table 1b.
Tumor dimension (cm) | |
Median | 9 mm |
Range | 1.2mm –19mm |
<1 cm | 56 (55%) |
>1cm and <2 cm | 45 (45%) |
Histology | |
Invasive ductal | 74 (75%) |
Invasive lobular | 16 (16%) |
Invasive tubular | 6 (6%) |
Invasive Ductal+Lobular | 1 (1%) |
Invasive colloid | 2 (2%) |
N/A* | 1 |
Nodal Status | |
N0 | 101** (100%) |
pN0 at sentinel node or axillary dissection | 96 (96%) |
No nodal assessment because of <5mm primary | 5 (5%) |
ER+ | 99 (99%) |
ER− | 1 (1%) |
PR+ | 65 (65%) |
PR− | 35 (35%) |
HER2 (+) | |
Yes | 5** (5%) |
No | 93 (95%) |
N/A | 2 |
Ki67 (available in 78/100) | |
Proliferation <14% | 68 (87%) |
Proliferation >14% | 9 (11%) |
insufficient tissue to perform the test
one patient with bilateral breast cancer
1pt received trastuzumab